134 related articles for article (PubMed ID: 37146833)
1. Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT.
Chang X; Liu J; Yang Q; Gao Y; Ding X; Zhao J; Li Y; Liu Z; Li Z; Wu Y; Zuo D
Biochem Pharmacol; 2023 Jun; 212():115582. PubMed ID: 37146833
[TBL] [Abstract][Full Text] [Related]
2. HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness.
Pegoraro S; Ros G; Piazza S; Sommaggio R; Ciani Y; Rosato A; Sgarra R; Del Sal G; Manfioletti G
Oncotarget; 2013 Aug; 4(8):1293-308. PubMed ID: 23945276
[TBL] [Abstract][Full Text] [Related]
3. Polyphenols Modulating Effects of PD-L1/PD-1 Checkpoint and EMT-Mediated PD-L1 Overexpression in Breast Cancer.
Messeha SS; Zarmouh NO; Soliman KFA
Nutrients; 2021 May; 13(5):. PubMed ID: 34069461
[TBL] [Abstract][Full Text] [Related]
4. HMGA1 interacts with β-catenin to positively regulate Wnt/β-catenin signaling in colorectal cancer cells.
Xing J; Cao G; Fu C
Pathol Oncol Res; 2014 Oct; 20(4):847-51. PubMed ID: 24696416
[TBL] [Abstract][Full Text] [Related]
5. Brazilein inhibits epithelial-mesenchymal transition (EMT) and programmed death ligand 1 (PD-L1) expression in breast cancer cells.
Wudtiwai B; Kodchakorn K; Shwe TH; Pothacharoen P; Phitak T; Suninthaboonrana R; Kongtawelert P
Int Immunopharmacol; 2023 May; 118():109988. PubMed ID: 36933493
[TBL] [Abstract][Full Text] [Related]
6. HMGA1 facilitates tumor progression through regulating Wnt/β-catenin pathway in endometrial cancer.
Han X; Cao Y; Wang K; Zhu G
Biomed Pharmacother; 2016 Aug; 82():312-8. PubMed ID: 27470368
[TBL] [Abstract][Full Text] [Related]
7. HMGA1 is induced by Wnt/beta-catenin pathway and maintains cell proliferation in gastric cancer.
Akaboshi S; Watanabe S; Hino Y; Sekita Y; Xi Y; Araki K; Yamamura K; Oshima M; Ito T; Baba H; Nakao M
Am J Pathol; 2009 Oct; 175(4):1675-85. PubMed ID: 19729480
[TBL] [Abstract][Full Text] [Related]
8. The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.
Bush BM; Brock AT; Deng JA; Nelson RA; Sumter TF
Cell Biochem Funct; 2013 Apr; 31(3):228-36. PubMed ID: 22961697
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 promotes colorectal cancer stem cell expansion by activating HMGA1-dependent signaling pathways.
Wei F; Zhang T; Deng SC; Wei JC; Yang P; Wang Q; Chen ZP; Li WL; Chen HC; Hu H; Cao J
Cancer Lett; 2019 May; 450():1-13. PubMed ID: 30776481
[TBL] [Abstract][Full Text] [Related]
10. HMGA1-TRIP13 axis promotes stemness and epithelial mesenchymal transition of perihilar cholangiocarcinoma in a positive feedback loop dependent on c-Myc.
Li Z; Liu J; Chen T; Sun R; Liu Z; Qiu B; Xu Y; Zhang Z
J Exp Clin Cancer Res; 2021 Mar; 40(1):86. PubMed ID: 33648560
[TBL] [Abstract][Full Text] [Related]
11. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
12. High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer.
Gorbounov M; Carleton NM; Asch-Kendrick RJ; Xian L; Rooper L; Chia L; Cimino-Mathews A; Cope L; Meeker A; Stearns V; Veltri RW; Bae YK; Resar LMS
Breast Cancer Res Treat; 2020 Jan; 179(1):25-35. PubMed ID: 31531802
[TBL] [Abstract][Full Text] [Related]
13. WNT/β-catenin regulatory roles on PD-(L)1 and immunotherapy responses.
Mortezaee K
Clin Exp Med; 2024 Jan; 24(1):15. PubMed ID: 38280119
[TBL] [Abstract][Full Text] [Related]
14. The innate immune effector ISG12a promotes cancer immunity by suppressing the canonical Wnt/β-catenin signaling pathway.
Deng R; Zuo C; Li Y; Xue B; Xun Z; Guo Y; Wang X; Xu Y; Tian R; Chen S; Liu Q; Chen J; Wang J; Huang X; Li H; Guo M; Wang X; Yang M; Wu Z; Wang J; Ma J; Hu J; Li G; Tang S; Tu Z; Ji H; Zhu H
Cell Mol Immunol; 2020 Nov; 17(11):1163-1179. PubMed ID: 32963356
[TBL] [Abstract][Full Text] [Related]
15. HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells.
Shah SN; Cope L; Poh W; Belton A; Roy S; Talbot CC; Sukumar S; Huso DL; Resar LM
PLoS One; 2013; 8(5):e63419. PubMed ID: 23658826
[TBL] [Abstract][Full Text] [Related]
16. High-mobility group AT-Hook 1 mediates the role of nuclear factor I/X in osteogenic differentiation through activating canonical Wnt signaling.
Wu X; Wang X; Shan L; Zhou J; Zhang X; Zhu E; Yuan H; Wang B
Stem Cells; 2021 Oct; 39(10):1349-1361. PubMed ID: 34028135
[TBL] [Abstract][Full Text] [Related]
17. Lessons from the Crypt: HMGA1-Amping up Wnt for Stem Cells and Tumor Progression.
Resar L; Chia L; Xian L
Cancer Res; 2018 Apr; 78(8):1890-1897. PubMed ID: 29618461
[TBL] [Abstract][Full Text] [Related]
18. miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells.
Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
Cell Biochem Funct; 2017 Oct; 35(7):464-471. PubMed ID: 29023799
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy enhances programmed cell death 1/ligand 1 expression via TGF-β induced epithelial mesenchymal transition in non-small cell lung cancer.
Funaki S; Shintani Y; Kawamura T; Kanzaki R; Minami M; Okumura M
Oncol Rep; 2017 Oct; 38(4):2277-2284. PubMed ID: 28849209
[TBL] [Abstract][Full Text] [Related]
20. DNER promotes epithelial-mesenchymal transition and prevents chemosensitivity through the Wnt/β-catenin pathway in breast cancer.
Wang Z; Li Z; Wu Q; Li C; Li J; Zhang Y; Wang C; Sun S; Sun S
Cell Death Dis; 2020 Aug; 11(8):642. PubMed ID: 32811806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
